» Articles » PMID: 38690295

Mesenchymal Stem Cells in Craniofacial Reconstruction: a Comprehensive Review

Overview
Specialty Biology
Date 2024 May 1
PMID 38690295
Authors
Affiliations
Soon will be listed here.
Abstract

Craniofacial reconstruction faces many challenges, including high complexity, strong specificity, severe injury, irregular and complex wounds, and high risk of bleeding. Traditionally, the "gold standard" for treating craniofacial bone defects has been tissue transplantation, which involves the transplantation of bone, cartilage, skin, and other tissues from other parts of the body. However, the shape of craniofacial bone and cartilage structures varies greatly and is distinctly different from ordinary long bones. Craniofacial bones originate from the neural crest, while long bones originate from the mesoderm. These factors contribute to the poor effectiveness of tissue transplantation in repairing craniofacial defects. Autologous mesenchymal stem cell transplantation exhibits excellent pluripotency, low immunogenicity, and minimally invasive properties, and is considered a potential alternative to tissue transplantation for treating craniofacial defects. Researchers have found that both craniofacial-specific mesenchymal stem cells and mesenchymal stem cells from other parts of the body have significant effects on the restoration and reconstruction of craniofacial bones, cartilage, wounds, and adipose tissue. In addition, the continuous development and application of tissue engineering technology provide new ideas for craniofacial repair. With the continuous exploration of mesenchymal stem cells by researchers and the continuous development of tissue engineering technology, the use of autologous mesenchymal stem cell transplantation for craniofacial reconstruction has gradually been accepted and promoted. This article will review the applications of various types of mesenchymal stem cells and related tissue engineering in craniofacial repair and reconstruction.

Citing Articles

Optimization and Implication of Adipose-Derived Stem Cells in Craniofacial Bone Regeneration and Repair.

Gu C, Tang Q, Li L, Chen Y Bioengineering (Basel). 2024; 11(11).

PMID: 39593759 PMC: 11592193. DOI: 10.3390/bioengineering11111100.

References
1.
Yanaga H, Udoh Y, Yamauchi T, Yamamoto M, Kiyokawa K, Inoue Y . Cryopreserved cultured epidermal allografts achieved early closure of wounds and reduced scar formation in deep partial-thickness burn wounds (DDB) and split-thickness skin donor sites of pediatric patients. Burns. 2001; 27(7):689-98. DOI: 10.1016/s0305-4179(01)00008-0. View

2.
Woltjen K, Michael I, Mohseni P, Desai R, Mileikovsky M, Hamalainen R . piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009; 458(7239):766-70. PMC: 3758996. DOI: 10.1038/nature07863. View

3.
Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

4.
De Long Jr W, Einhorn T, Koval K, McKee M, Smith W, Sanders R . Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am. 2007; 89(3):649-58. DOI: 10.2106/JBJS.F.00465. View

5.
Tu C, Cheng N, Yu J, Pan Y, Tai W, Chen Y . Adipose-derived stem cell spheroid-laden microbial transglutaminase cross-linked gelatin hydrogel for treating diabetic periodontal wounds and craniofacial defects. Stem Cell Res Ther. 2023; 14(1):20. PMC: 9898981. DOI: 10.1186/s13287-023-03238-2. View